Robert Whitfield MDAmerica's Breast Implant Illness Expert™

Ozempic Dangers: Compounding, Dosage & 'Ozempic Face' Explained! #shorts

28 Jan 2026 · 1 min

Watch on YouTube

1:01

A short spoken clip by Robert Whitfield MD warning about risks when patients self-inject GLP-1 drugs (e.g., Ozempic), especially compounded versions with variable potency. The speaker notes patients sometimes exceed labeled doses, which can increase fat loss and appetite suppression, and that reduced inflammation and symptomatic improvement can make stopping undesirable; emphasizes need for patient education and supervision.

Chapters

The problem I've ran into is people were injecting the drug. The drug may be compounded. The actual amount of the drug within the compounded formula they were given may have been too low. May have been absolutely. It was on the label, on the bottle. It may have been high. So the problem is if it's high, of course, then you're burning more fat. So ozempic phase or all that stuff, you know, has to be addressed through patient education. Pat should not, in my opinion, just be set free to inject themselves with peptides. People will do more than the labeled dose, which I find all the time. And then because they're so effective at making people feel satiated or not hungry anymore and they lose weight relatively easily, they don't want to come off of them. Sometimes it lowers inflammation to the point where they feel a lot better and they don't want to come off of them.